Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - paricalcitol - capsules, soft - 4 microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sodium picosulfate - capsule, soft - 2.5 milligram(s) - contact laxatives; sodium picosulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - menthol; menthone; alpha pinene; borneol; cineole; camphene; beta pinene - gastro-resistant capsule, soft - percent volume/volume

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - beta pinene; cineole; camphene; alpha pinene; fenchone; anethole; borneol - gastro-resistant capsule, soft - 12.5 percent volume/volume

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 10 mg - capsule, soft - excipient ingredients: corn glycerides; ethanol; propylene glycol; dl-alpha-tocopherol; peg-40 hydrogenated castor oil; glycerol; gelatin; titanium dioxide; isopropyl alcohol; hypromellose; purified water; cochineal; aluminium chloride; sodium hydroxide - as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see precautions). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with the quality of life. for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 100 mg - capsule, soft - excipient ingredients: ethanol; iron oxide black; propylene glycol; gelatin; glycerol; peg-40 hydrogenated castor oil; titanium dioxide; corn glycerides; dl-alpha-tocopherol; isopropyl alcohol; hypromellose; purified water; cochineal; aluminium chloride; sodium hydroxide - as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cystostatic drugs have failed, or are not tolerated, or are considered inapropriate, and when renal function is unimpaired (see warnings). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. additional indications from 11 june 1997: for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 50 mg - capsule, soft - excipient ingredients: propylene glycol; dl-alpha-tocopherol; ethanol; gelatin; corn glycerides; peg-40 hydrogenated castor oil; titanium dioxide; glycerol; isopropyl alcohol; hypromellose; purified water; cochineal; aluminium chloride; sodium hydroxide - changes as described in the letter 23 december 1998 from b wall.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 25 mg - capsule, soft - excipient ingredients: gelatin; peg-40 hydrogenated castor oil; corn glycerides; dl-alpha-tocopherol; titanium dioxide; iron oxide black; ethanol; glycerol; propylene glycol; isopropyl alcohol; hypromellose; purified water; cochineal; aluminium chloride; sodium hydroxide - changes as described in the letter 23 december 1998 from b wall

Ireland - English - HPRA (Health Products Regulatory Authority)

besins healthcare ireland limited - progesterone - vaginal capsule, soft - 300 milligram(s) - progesterone

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - capsules - see ingredients - each capsule contains codeine phosphate 10 mg ibuprofen 2oo mg paracetamol 250 mg